Biomarker Discovery-
$4,684N01FY2019ESNIH
Battelle Memorial Institute, Richland OH
Investigators
Abstract
Stemina has a proprietary assay (devTOXqP?) that is a biomarker-based, human, in vitro assay for prediction of developmental toxicity that utilizes key biomarkers identified using our metabolomics platform. Keywords: toxicity, biomarkers, in vitro toxicology, metabolomics, developmental toxicology.
View original record on NIH RePORTER →